1. Home
  2. SIMO vs SYRE Comparison

SIMO vs SYRE Comparison

Compare SIMO & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$279.94

Market Cap

8.5B

Sector

Technology

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$86.29

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIMO
SYRE
Founded
1995
2013
Country
Hong Kong
United States
Employees
N/A
112
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.6B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
SIMO
SYRE
Price
$279.94
$86.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
★ $118.13
$85.08
AVG Volume (30 Days)
708.6K
★ 1.1M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
★ 0.92%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.27
N/A
Revenue Next Year
$12.78
N/A
P/E Ratio
$36.09
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$79.76
$15.49
52 Week High
$355.00
$110.18

Technical Indicators

Market Signals
Indicator
SIMO
SYRE
Relative Strength Index (RSI) 56.32 37.10
Support Level $230.06 $82.83
Resistance Level $314.34 $93.65
Average True Range (ATR) 15.86 3.70
MACD 3.07 -0.07
Stochastic Oscillator 81.50 27.33

Price Performance

Historical Comparison
SIMO
SYRE

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid-state storage devices. Its only operating segment is to develop NAND flash controllers and SSD solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company's products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: